| TENX Stock | | | USD 6.01 0.07 1.18% |
Tenax Therapeutics financial indicator trend analysis is much more than just breaking down Tenax Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tenax Therapeutics is a good investment. Please check the relationship between Tenax Therapeutics Accounts Payable and its Common Stock accounts. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Tenax Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Tenax Stock please use our
How to Invest in Tenax Therapeutics guide.
Accounts Payable vs Common Stock
Accounts Payable vs Common Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Tenax Therapeutics Accounts Payable account and
Common Stock. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Tenax Therapeutics' Accounts Payable and Common Stock is -0.31. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Common Stock in the same time period over historical financial statements of Tenax Therapeutics, assuming nothing else is changed. The correlation between historical values of Tenax Therapeutics' Accounts Payable and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Tenax Therapeutics are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Accounts Payable i.e., Tenax Therapeutics' Accounts Payable and Common Stock go up and down completely randomly.
Correlation Coefficient | -0.31 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Accounts Payable
An accounting item on the balance sheet that represents Tenax Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Tenax Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Common Stock
Most indicators from Tenax Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tenax Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
World Market Map to better understand how to build diversified portfolios, which includes a position in Tenax Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Tenax Stock please use our
How to Invest in Tenax Therapeutics guide.At this time, Tenax Therapeutics'
Sales General And Administrative To Revenue is fairly stable compared to the past year.
Enterprise Value Over EBITDA is likely to rise to 0.49 in 2024, whereas
Selling General Administrative is likely to drop slightly above 4.9
M in 2024.
Tenax Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Tenax Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tenax Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Tenax Stock Analysis
When running Tenax Therapeutics' price analysis, check to
measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.